See more : Omega Alpha SPAC (OMEG) Income Statement Analysis – Financial Results
Complete financial analysis of Karex Berhad (5247.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Karex Berhad, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Immo Moury SCA (IMMOU.BR) Income Statement Analysis – Financial Results
- Rainbow Rare Earths Limited (RBWRF) Income Statement Analysis – Financial Results
- CASH Financial Services Group Limited (0510.HK) Income Statement Analysis – Financial Results
- Avivagen Inc. (VIV.V) Income Statement Analysis – Financial Results
- Covetrus, Inc. (CVET) Income Statement Analysis – Financial Results
Karex Berhad (5247.KL)
About Karex Berhad
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. It offers personal lubricants; probe covers; and Foley balloon catheters for transurethral drainage of the urinary bladder, as well as gloves. The company also offers hand sanitizer and pre-vulcanised latex products; and wholesales healthcare products. The company operates in Africa, Asia, the Americas, and Europe. It serves brand owners, governments, non-governmental organizations, and retail purchasers. Karex Berhad was founded in 1988 and is based in Port Klang, Malaysia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 507.85M | 532.07M | 421.64M | 419.82M | 395.07M | 378.48M | 408.01M | 361.45M | 343.62M | 298.09M | 219.93M | 231.39M | 188.75M | 181.75M | 157.44M |
| Cost of Revenue | 336.59M | 396.21M | 329.06M | 322.10M | 307.36M | 289.30M | 300.88M | 250.26M | 229.07M | 200.31M | 155.95M | 171.47M | 155.89M | 156.87M | 117.32M |
| Gross Profit | 171.26M | 135.85M | 92.58M | 97.72M | 87.70M | 89.19M | 107.13M | 111.19M | 114.55M | 97.79M | 63.98M | 59.92M | 32.87M | 24.88M | 40.13M |
| Gross Profit Ratio | 33.72% | 25.53% | 21.96% | 23.28% | 22.20% | 23.56% | 26.26% | 30.76% | 33.34% | 32.80% | 29.09% | 25.89% | 17.41% | 13.69% | 25.49% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 70.72M | 64.33M | 50.81M | 50.14M | 49.87M | 49.32M | 44.93M | 38.88M | 33.90M | 21.56M | 9.93M | 10.07M | 9.21M | 8.68M | 7.89M |
| Selling & Marketing | 56.14M | 53.94M | 45.31M | 47.99M | 34.30M | 36.59M | 46.05M | 34.78M | 19.15M | 14.97M | 9.13M | 9.70M | 9.31M | 7.08M | 7.68M |
| SG&A | 126.86M | 118.27M | 96.11M | 98.13M | 84.17M | 85.91M | 90.98M | 73.66M | 53.05M | 36.53M | 19.05M | 19.77M | 18.51M | 15.76M | 15.57M |
| Other Expenses | 4.91M | 0.00 | -671.00K | -2.35M | 0.00 | -927.00K | 2.11M | 2.04M | -12.96M | -9.87M | 3.15M | -657.00K | 81.00K | 68.00K | 414.00K |
| Operating Expenses | 131.77M | 113.43M | 95.44M | 95.77M | 80.54M | 84.98M | 93.08M | 75.69M | 40.08M | 26.66M | 22.21M | 19.77M | 18.51M | 15.76M | 15.57M |
| Cost & Expenses | 468.36M | 509.64M | 424.51M | 417.87M | 387.90M | 374.27M | 393.97M | 325.95M | 269.15M | 226.97M | 178.16M | 191.24M | 174.40M | 172.63M | 132.89M |
| Interest Income | 337.00K | 134.00K | 309.00K | 186.00K | 517.00K | 1.02M | 1.48M | 2.74M | 5.54M | 3.33M | 1.33M | 150.00K | 144.00K | 104.00K | 38.00K |
| Interest Expense | 8.83M | 7.43M | 3.93M | 2.66M | 2.49M | 1.42M | 1.25M | 1.19M | 654.00K | 1.17M | 1.56M | 2.50M | 2.65M | 1.99M | 1.12M |
| Depreciation & Amortization | 25.51M | 26.80M | 23.43M | 23.00M | 20.83M | 15.65M | 14.02M | 11.54M | 9.16M | 7.67M | 5.13M | 5.89M | 3.56M | 3.48M | 3.38M |
| EBITDA | 65.33M | 49.36M | 20.88M | 25.13M | 28.51M | 20.88M | 29.54M | 49.78M | 89.17M | 82.13M | 48.23M | 44.53M | 22.62M | 15.27M | 26.26M |
| EBITDA Ratio | 12.86% | 9.28% | 4.95% | 5.99% | 7.22% | 5.52% | 7.24% | 13.77% | 25.95% | 27.55% | 21.93% | 19.63% | 11.14% | 7.24% | 16.76% |
| Operating Income | 39.49M | 22.43M | -2.86M | 1.94M | 7.17M | 4.21M | 14.05M | 35.50M | 74.47M | 71.13M | 41.77M | 38.49M | 17.03M | 9.59M | 20.77M |
| Operating Income Ratio | 7.78% | 4.21% | -0.68% | 0.46% | 1.81% | 1.11% | 3.44% | 9.82% | 21.67% | 23.86% | 18.99% | 16.64% | 9.02% | 5.28% | 13.19% |
| Total Other Income/Expenses | -8.49M | -7.29M | -3.63M | -2.48M | -1.97M | -406.00K | 229.00K | 1.55M | 4.89M | 2.16M | -229.00K | -362.00K | 603.00K | -1.89M | -1.08M |
| Income Before Tax | 31.00M | 15.13M | -6.49M | -534.00K | 5.19M | 3.80M | 14.28M | 37.05M | 79.35M | 73.28M | 41.54M | 36.14M | 14.53M | 7.70M | 19.69M |
| Income Before Tax Ratio | 6.10% | 2.84% | -1.54% | -0.13% | 1.31% | 1.01% | 3.50% | 10.25% | 23.09% | 24.58% | 18.89% | 15.62% | 7.70% | 4.24% | 12.51% |
| Income Tax Expense | 7.56M | 4.65M | -297.00K | -680.00K | 1.70M | 747.00K | 4.09M | 8.24M | 12.93M | 13.55M | 6.96M | 7.12M | 2.51M | 715.00K | 3.16M |
| Net Income | 23.44M | 10.48M | -6.19M | -1.02M | 228.00K | 2.53M | 10.10M | 27.95M | 66.69M | 59.55M | 34.59M | 29.03M | 12.02M | 6.99M | 16.53M |
| Net Income Ratio | 4.62% | 1.97% | -1.47% | -0.24% | 0.06% | 0.67% | 2.48% | 7.73% | 19.41% | 19.98% | 15.73% | 12.55% | 6.37% | 3.84% | 10.50% |
| EPS | 0.02 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.07 | 0.06 | 0.05 | 0.03 | 0.01 | 0.01 | 0.02 |
| EPS Diluted | 0.02 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.07 | 0.06 | 0.05 | 0.03 | 0.01 | 0.01 | 0.02 |
| Weighted Avg Shares Out | 1.05B | 1.05B | 1.05B | 1.03B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 938.96M | 685.06M | 911.25M | 911.25M | 911.25M | 911.25M |
| Weighted Avg Shares Out (Dil) | 1.05B | 1.05B | 1.05B | 1.03B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 938.96M | 685.06M | 911.25M | 911.25M | 911.25M | 911.25M |
Source: https://incomestatements.info
Category: Stock Reports